ACP Journal Club. Apixaban reduced stroke or systemic embolism in AF more than warfarin regardless of type or duration of AF

Ann Intern Med. 2013 Jul 16;159(2):JC8. doi: 10.7326/0003-4819-159-2-201307160-02008.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Female
  • Humans
  • Male
  • Pyrazoles / therapeutic use*
  • Pyridones / therapeutic use*
  • Stroke / prevention & control*
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridones
  • apixaban
  • Warfarin